The authors reply

New England Journal of Medicine

Volumn 361, Issue 26, 2009, Pages 2579-2580

  Hurst, Lawrence C ^a   Badalamente, Marie ^a   Smith, Theodore ^b  

^a STONY BROOK UNIVERSITY   (United States)

^b Auxilium Pharmaceuticals   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGENASE CLOSTRIDIUM HISTOLYTICUM; COLLAGENASE INHIBITOR; UNCLASSIFIED DRUG;

DRUG SAFETY; DUPUYTREN CONTRACTURE; FINGER; FLEXOR REFLEX; FLEXOR TENDON; HAND PALM; HUMAN; INCIDENCE; INJECTION; LETTER; METACARPOPHALANGEAL JOINT; PHARMACOLOGICAL PARAMETERS; PHYSICIAN; PREVALENCE; PRIORITY JOURNAL; PROXIMAL INTERPHALANGEAL JOINT; RECURRENT DISEASE; SKIN; SURGICAL TECHNIQUE; TENDON RUPTURE; TREATMENT OUTCOME;

EID: 73549089703     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: None     Document Type: Letter

References (3)

1. Hurst LC, Badalamente MA. Nonoperative treatment of Dupuytren's disease. Hand Clin 1999;15:97-107.
2. Loos B, Puschkin V, Horch RE. 50 Years experience with Dupuytren's contracture in the Erlangen University Hospital - a retrospective analysis of 2919 operated hands from 1956 to 2006. BMC Musculoskelet Disord 2007;8:60.
3. Briefing information for the September 16, 2009, meeting of the Arthritis Drug Advisory Committee. Silver Spring, MD: Food and Drug Administration. (Accessed December 3, 2009, at www.fda.gov/AdvisoryCommittees/ CommitteesMeetingMaterials/Drugs/ArthritisDrugsAdvisoryCommittee/ucm182012.htm.)